Why the study?
Does ACE genotype distribution differ in patients with sarcoidosis compared to healthy controls, and does it affect serum ACE levels?
Does ACE genotype distribution differ in patients with sarcoidosis compared to healthy controls, and does it affect serum ACE levels?
ACE genotype distribution is not altered in sarcoidosis, but both ACE genotype and disease stage contribute to determining serum ACE levels.
No takes yet. Share an insight, caveat, or question.
ACE genotyping adds no diagnostic value in sarcoidosis; leaves open whether sACE levels, adjusted for genotype, aid disease monitoring.
Arbustini et al. (1996) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: